Incretin is a hormone that is secreted from the enteroendocrine cells in response to food ingestion and stimulates pancreatic β-cells to produce insulin, which leads to postprandial glucose stabilization. Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide are two principal incretin hormones that are secreted from L-cells in the ileum and K-cells in the duodenum and jejunum, respectively. Intact incretin, a biologically active form of incretin, is degraded by the enzyme dipeptidyl peptidase-4 (DPP-4) to an inactive metabolite shortly after its secretion. Several reports describe that serum DPP-4 activity is increased in obesity , and less than 5% of intact GLP-1 finally reaches systemic circulation.
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